Proceeding contribution from Lord Bassam of Brighton (Labour) in the House of Lords on Thursday, 2 March 2006. It occurred during Parliamentary proceeding on Drug Classification System.
Drug Classification System
My Lords, we shall study that with interest and again I am grateful for the clarification. I had not meant to be so provocative at the outset of my speech. The views of the noble Lord, Lord Cobbold, are trenchant and well-known. It is fair to say that they do not coincide with those of Her Majesty’s Government on approaches to drug matters. That is not to say that the debate which he and the noble Lord, Lord Mancroft, together have advanced with such conviction is not a debate worth having because I believe it is. It rightly focuses on a whole range of other concerns relating to the drugs issue. The objective of all noble Lords in this debate is, I suspect, at one with their concern and commitment to reducing the harm done by drugs to individuals, families, communities and society at large. I believe that is a shared objective. The path to that objective may differ, but there is no doubt that the goal is the same. The noble Lord, Lord Cobbold, made an eloquent speech on the merits of reducing drug controls on illegal drugs by introducing a greater degree of regulation. It is for me to expand on why the Government oppose that view for the moment. For now, I wish to focus on the classification system for drugs in this country and on the forthcoming review. My right honourable friend the Home Secretary made an announcement to Parliament on 19 January on various drug matters, some of which, like the recent report on cannabis of the Advisory Council on the Misuse of Drugs, have already been touched on in the debate. The primary purpose of the announcement was to make it clear that my right honourable friend accepted the recommendation of the Advisory Council on the Misuse of Drugs that cannabis should remain a class C drug. However, in accepting that recommendation, he made clear his desire for the system of drug classification in the United Kingdom to be subject to a full review. That has been welcomed by many Members of your Lordships’ House during this debate and, indeed, the noble Baroness, Lady Seccombe, acknowledged the importance of that review. The issue of cannabis is instructive here. The reclassification of cannabis in 2004 from class B to C was done, I believe, for all the right reasons and was based on the recommendations of the advisory council. However, many drew the wrong conclusions—that cannabis was no longer harmful and that in some way use was acceptable. The ensuing confusion may be partly the consequence in our view of an outdated classification system. The current system of classifying drugs into the three classes A, B and C on their relative harms was established by the Misuse of Drugs Act 1971. We are all aware that the patterns of drug misuse in the United Kingdom have changed quite dramatically in the past 35 years. It is in our view therefore appropriate that the system of control should now be reviewed to ensure that a clearer system is in place. The Government’s review on classification will begin in a few weeks with the publication of a consultation paper. Until the contents of the consultation paper are more widely known, I cannot comment in detail about it. The Government are committed to engaging with our key stakeholders, whose views will be taken carefully into consideration. I should say at the outset that the consultation document will take forward an improved system of control; it will not be considering options on legalising drugs. The Government have been very firm in stating that position. They have made it clear on many occasions that they firmly oppose legalisation and I repeat that commitment today. Indeed, the point was made in response to a Question from the noble Lord, Lord Cobbold, in this House on 26 January, when I clarified exactly our position. From his many contributions to these debates, it is clear that the noble Lord, Lord Cobbold, does not support the system of prohibition of drugs. But I am bound to say that the Government have no intention of legalising or decriminalising the recreational use of controlled drugs in the manner that he has advocated. Our opposition was made crystal clear in our response to the 2002 Home Affairs Committee report, The Government’s Drugs Policy: Is It Working?. We said:"““We do not accept that legalisation and regulation is now, or will be in the future, an acceptable response to the presence of drugs””." The Government’s view is that the drugs that are subject to our misuse of drugs legislation are controlled for very good reasons. Many, such as heroin and crack cocaine, are highly addictive and harmful to health. We believe that it makes sense for them to remain controlled drugs whose unauthorised production, supply and possession are, and will remain, illegal. Legalisation of currently illegal drugs would run entirely counter to the Government’s health and education messages. Our educational message, to young people in particular, is that all controlled drugs are harmful and that no one should take them. To legalise their supply for personal consumption would send a disastrously wrong message to the majority of young people, who do not take drugs, with the potential risk of increased drug use and abuse. The Government’s objective is to reduce the use of all illegal drugs substantially. In our view, lessening controls would lead to increased consumption owing to more ready access to the supply of illicit substances. Increased use of drugs would mean a consequent drain on the health services and increased misery to individuals, families and communities. While our drugs laws cannot be expected to eliminate drug use, there is no doubt that they help to limit use and deter experimentation. While it is likely that there would be a reduction in acquisitive crime if drugs were legalised, it is important to remember that other crime is associated with drug misuse—for example, crimes committed while people are in a state of intoxication. The legalisation of drugs would not eliminate the crime committed by organised career criminals associated with drugs; such criminals would simply seek new sources of illicit revenue and move on to other crimes or other aspects of the drugs world to seek their profits. Unilateral action by the Government towards legalisation would undoubtedly encourage drug tourism, as the Dutch have discovered. They are now exploring ways to tackle that problem. However, there is a more fundamental point here. Drugs are a global problem. Very often they are produced in one country and consumed in another. A co-ordinated international response is vital in our commitment to tackle drug misuse. The United Kingdom is a signatory to the UN convention on drug control and takes its responsibility seriously. Legalisation, even for a few drugs, would cause substantial damage to international relations and diminish the United Kingdom’s standing among our international partners. That said, the Government accept that more needs to be done. In particular, this includes a far stronger emphasis on dealing with problematic drug users and the problems that they pose on reducing the harm from drug misuse to their own well being and that of others, given that they account for so much of the social and economic costs of drug misuse and drug-related crime, and on preventing young people, especially those most at risk, becoming the problematic users of the future. The Government are engaging those individuals causing most harm to themselves and to others in treatment, dealing with those who commit crime to fund a drug habit by providing a gateway into treatment at every point in the criminal justice system, and by investing in education and publicity campaigns to turn people away from drugs. It is our contention that the drug strategy is delivering tangible improvements in communities across the country. This debate is timely in looking further at the drug strategy. Another key objective is to keep drug users off the drugs that fuel crime by providing effective treatment services. I can report that there are now record numbers of drug misusers entering and—more importantly—staying in treatment. The figures show that the Government are making great strides in treatment provision: 89 per cent more people entered treatment in 2004–05 than in 1998; 27 per cent more people were in contact with structured treatment services in 2004–05 than in the previous year; and 75 per cent of individuals entering treatment in 2004–05 were retained or successfully completed treatment programmes, up by 20 per cent from 2002. As a number of noble Lords have commented, treatment works and is cost effective. The noble Baroness, Lady Walmsley, made that point. It is certainly the case that for every pound spent on treatment, at least £9.50 is saved in crime and related health costs. Drug-related deaths in England have fallen to their lowest level since 1998—from 1,571 in 1999 to some 1,388 in 2003. There may be some slight variation in figures since then, but the simple point is that drug-related deaths are falling and we are getting the numbers moving in the right direction. More drugs workers have been recruited; there are now some 10,000 and rising, as of September 2005, an increase of almost 50 per cent from March 2002. To critics of our strategy, I simply say that we have fairly rapidly increased the investment in this important aspect of countering the drugs problem or drugs menace. Drug-related crime has also fallen. Acquisitive crime fell by 12 per cent in the year to April 2005. In October 2005 more than 2,000 drug-misusing offenders entered treatment through the drug intervention programme. The Drugs Act 2005 brought into force the additional provisions on testing and arrest and on required assessment. These measures were successfully implemented across three forces in December 2005 and are to be implemented in all drug intervention programme intensive areas in England from the end of March this year. At the same time restriction on bail provisions will be rolled out to all local justice areas in England. Much consideration was given during the course of the debate to the issue of cannabis. The noble Baroness, Lady Murphy, in particular dwelt at some length on that. I know that this is an aspect of government policy where there is appreciable debate. As I mentioned in my introduction, the announcement of the review of the classification system was in the context of the Home Secretary’s decision to keep cannabis as a class C drug under the Misuse of Drugs Act 1971. Following a request from the Home Secretary in March last year, the advisory council produced an extremely comprehensive report on cannabis. One of the key conclusions was the stronger evidence of a link between taking cannabis and developing mental health problems. However, the overall risk remains very low. The advisory council stressed the significant harms of taking cannabis, particularly for those with existing mental health problems, such as schizophrenia. The noble Baroness, Lady Murphy, rightly said that there is a debate about the relative harm of cannabis use, and that debate will, no doubt, continue. However, the links to mental health problems and other harms from class B drugs, such as amphetamines, were considerably higher. In those circumstances, the advisory council concluded that the classification of class C was still appropriate. The council also considered claims of increased strength. It found some evidence of stronger varieties of skunk types of cannabis, typically grown by hydroponic methods, although more research is required. The advisory council reported that skunk varieties were still a minority of the cannabis taken in this country. It is certainly the case that claims that cannabis strengths are generally 10, 20 or 30 times higher than the 1980s are without any supportive evidence. One of the key priorities now is to deliver a large-scale education programme, for which noble Lords called in the debate, in particular, the noble Baroness, Lady Walmsley. The cannabis public information campaign will introduce a comprehensive package of education and public health measures. The aims are to provide effective education in school about the risks posed by cannabis and to send the right messages about the harms caused by cannabis. The campaign will target young people through the highly successful ““Frank”” campaign. The objective is to ensure that no one is left in any doubt about the harms and legal status of cannabis. The Association of Chief Police Officers made clear its support for the retention of cannabis as a class C drug. The Home Secretary and the police have agreed that there needs to be focused police effort to take strong action to reduce the supply of cannabis. Plans for taking that work forward are being developed and will be announced in coming weeks. Noble Lords are rightly concerned about the level of use of cannabis. Indeed, during the debate on the classification of cannabis in November 2003, the noble Lord, Lord Hodgson, successfully moved an amendment to reflect his concern that reclassification of cannabis might lead to increased use. Evidence from the British Crime Survey clearly shows that cannabis use is steadily falling. In the past year, the use of cannabis by 16 to 24 year olds had fallen by 16 per cent since 1998. We do not see that a simply a by-product of reclassification. In addition, recent powers in the Drugs Act 2005 are strengthening the hand of the police: cannabis suppliers caught dealing on or in the vicinity of schools or using children as couriers will now receive tougher sentences from the courts. The noble Lord, Lord Young of Norwood Green, referred to the misuse of khat and the noble Lord, Lord Avebury, raised the issue on 26 January. There was insufficient time on that occasion to set out fully the Government’s position, but I am pleased to be able to do so this afternoon. The announcement on 19 January, to which reference has been made, contained a reference to the plant khat. Following a request from the then Home Office Minister, Caroline Flint, in February, the Advisory Council on the Misuse of Drugs began a study of khat misuse and whether there was a good case for making it a controlled drug. Khat is unlike other drugs because it is misused by only one or two ethnic groups, mainly the Somali community. There is little doubt that Somali mothers are particularly worried about it—the noble Baroness, Lady Masham, referred to that. It is a very understandable concern. The Advisory Council on the Misuse of Drugs made several recommendations about its control that were related to improving the quality of education, prevention and treatment. The Government have agreed to the council’s recommendations in full, including the recommendation not to make khat a controlled drug. Time is against me. There is much more that I could cover in this debate and in my summing up of its importance. Several questions were asked about particular issues, and I shall try to answer one or two of the more pertinent ones. There was particular concern about methylamphetamines, which the noble Baroness, Lady Masham of Ilton, talked about. She thought that some pressure should be applied to raise the drug’s level of classification. The advisory council found that it was right to leave its classification as a class B drug. We have accepted that recommendation for the time being. The view is that, although this drug is highly addictive—it is known as crystal meth or ice—there is a fear that it will come into this country and that its use will be much more prevalent. So far, the evidence does not suggest that that is the case, but we acknowledge that the position on that drug could change quite quickly, and it is obviously important that we need to monitor the situation very closely. The Home Secretary has asked to be advised later this year, and the position on its classification will be kept carefully under review. We believe that to be the right approach. A question was asked about rape drugs and their classification, which the advisory council is considering. It is worth pointing out that some of the quoted rape drugs already fall within the system of classification under class C. So we acknowledge and accept the importance of keeping that classification under view. We think that there is much to be commended in our strategy, and that we have made great progress. Evidence of declining drug use shows that that is the case. We recognise, as the noble Baroness, Lady Walmsley, does, the importance and value of education. We continue to increase investment in the important area of education in schools, and I think that our record there is very encouraging, as the noble Baroness recognised. I gave several statistics earlier on the increased number of those in treatment, but it is clear that we must concentrate in future on increasing public awareness of the threat, the menace and the problems associated with all drugs. The review of classification will be very helpful to us in ensuring that each drug that presents a particular difficulty is in the right position. No doubt there will be passionate discussions on whether the classification system, when reviewed, is the right one. Whatever the outcome of the review, I want to make it absolutely clear from the Government Benches that we are committed to maintaining controls on drugs included in the international conventions to which the United Kingdom is a signatory. It is important that the message comes clearly from Government that we are intent on reforming classification but that we reject any suggestion that the legalisation, decriminalisation or regulation of illegal drugs can be a solution. Internationally, that is an accepted policy position. We seek to work with our partners to achieve common objectives, and I think that, from the levels of investment that we are now putting into it and the changes in public behaviour that are being achieved as a result, our drug strategy shows that we are on the right path. We continue to adopt that approach. I reject, in part, the friendly criticism made by the noble Baroness, Lady Seccombe, that our policies are confused; I do not think that they are. Some of the statistics that I provided earlier clearly identify successes and suggest that we are going in the right direction. Indeed, they are built on policies that have been developed by successive governments. It is certainly right that we should review classification now. As I am sure the noble Baroness would willingly concede, a 35-year wait is a very long one, and we need to ensure that things are in the right place at the right time. I am grateful to the noble Lord, Lord Cobbold, for providing us with the opportunity to have this debate today. It has been of great value. I have enjoyed it and have learnt a great deal from it, and I hope that others have, too.
Secondary information
- Type
- Proceeding contribution
- Reference
- 679 c415-21
- Session
- 2005-06
- Chamber / Committee
- House of Lords chamber
- Subjects
- Crime Cannabis Decriminalisation Health hazards Drugs Health education Misuse Rape Mental health Rehabilitation Methamphetamine Khat
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2024-04-21 21:58:30 +0100
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_304583
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_304583
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_304583